Suppression subtractive hybridisation: Application in the discovery of novel pharmacological targets

Pharmacogenomics

Volumn 1, Issue 1, 2000, Pages 101-108

  Wang, Xinkang ^a   Feuerstein, Giora Z ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Cerebral ischaemia; Genomics; Preconditioning; Subtraction; Suppression PCR

Indexed keywords

DNA;

BRAIN ISCHEMIA; GENETICS; HUMAN; ISCHEMIC PRECONDITIONING; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PHARMACOGENETICS; REVIEW;

BRAIN ISCHEMIA; DNA; HUMANS; ISCHEMIC PRECONDITIONING; NUCLEIC ACID HYBRIDIZATION; PHARMACOGENETICS;

EID: 0034139511     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.1.1.101     Document Type: Article

References (17)

1. HEDRICK SM, COHEN DI, NIELSON EA, DAVIS MM: Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. Nature (1984) 308:149-153.
2. LIANG P, PARDEE AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (1992) 257:967-970. This paper described for the first time the use of mRNA differential display to identify differentially expressed genes.
3. VELCULESCU VE, ZHANG L, VOGELSTEIN B, KINZLER KW: Serial analysis of gene expression. Science (1995) 270:484-487. This paper reported the technique referred to as SAGE to identify a small sequence tag for expressed gene profiles.
4. DIATCHENKO L, LAU YF, CAMPBELL AP et al.: Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. USA (1996) 93:6025-6030. This paper introduced for the first time the technique of suppression subtractive hybridisation. This technique was successfully used to identify genes that are specifically expressed in a particular tissue. Since this technique is based upon the suppression PCR and subtraction, it is sensitive to identify genes with low and moderate levels of differential expression.
5. SCHENA M, HELLER RA, THERIAULT TP, KONRAD K, LACHENMEIER E, DAVIS RW: Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol. (1998) 16:301-306.
6. BARONE FC, WHITE RF, SPERA PA et al.: Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke (1998) 29:1937-1950.
7. KITAGAWA K, MATSUMOTO M, KUWABARA K et al.: 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res. (1991) 561:203-211.
8. DIATCHENKO L, LUKYANOV S, LAU YF, SIEBERT PD: Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Methods Enzymol. (1999) 303:3-49-380. This article provided a comprehensive protocol of the suppression subtractive hybridisation technique.
9. SIEBERT PD, CHENCHIK A, KELLOGG DE, LUKYANOV KA, LUKYANOV SA: An improved PCK method for walking in uncloned genomic DNA. Nucleic Acids Res. (1995) 23:1087-1088.
10. CHOMCZYNSKI P, SACCHIN: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. (1987) 162:156-159.
11. WANG XK, YAISH-OHAD S, LI X, BARONE FC, FEUERSTEIN GZ: Use of suppression subtractive hybridization strategy for discovery of increased tissue inhibitor of matrix metalloproteinase-1 gene expression in brain ischemic tolerance. J. Cereb. Blood Flow Metab. (1998) 18:1173-1177. This paper provided an example for the use of suppression subtractive hybridisation to identify disease-related genes. Dot blot analysis (of differential hybridisation) was applied to facilitate the evaluation of differentially expressed genes after the suppression subtractive hybridisation procedure.
12. VON STEIN OD, THIES W, HOFMANN, M: A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res. (1997) 25:2598-2602.
13. YANG GP, ROSS DT, KUANG WW, BROWN PO, WEIGEL RJ: Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res. (1999) 27:1517-1523. A clever use of cDNA microarray analysis of suppression subtractive hybridisation clones.
14. WANG XK, BARONE FC, WHITE RF, FEUERSTEIN GZ: Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TLMP-1) increased gene expression following focal stroke. Stroke (1998) 29:516-520.
15. ROMANIC AM, WHITE RF, ARLETH AJ, OHLSTEIN EH, BARONE FC: Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke (1998) 29:1020-1030.
16. LISITSYN N, LISITSYN N, WIGLER M: Cloning the differences between two complex genomes. Science (1993) 259:946-951.
17. HUBANK M, SCHATZ DG: Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. (1994) 22:5640-5648.